NCT00051909

Data

{
  "briefSummary": "Study of an investigational medication for the treatment of Alzheimer's Disease in patients who are not taking Aricept, Reminyl, Exelon.",
  "completionDate": "2003-06",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 200,
  "enrollmentType": null,
  "nctId": "NCT00051909",
  "phase": "PHASE2",
  "sponsorId": "eli-lilly-and-company",
  "startDate": "2002-11",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00051909"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version